| CPC C12Q 1/6806 (2013.01) [C12Q 1/6818 (2013.01); C12Q 1/682 (2013.01); C12Q 1/686 (2013.01); C12Q 1/70 (2013.01); B82Y 5/00 (2013.01); C12N 2310/151 (2013.01)] | 9 Claims |
|
1. A DNA nanostructure comprising four DNA oligonucleotides, wherein the first oligonucleotide has the sequence of SEQ ID NO: 2, the second oligonucleotide has the sequence of SEQ ID NO: 3, the third oligonucleotide has the sequence of SEQ ID NO: 4, and the fourth oligonucleotide has a length of 30 to 80 nucleotides and comprises a sequence that is at least 95% complementary to a target viral nucleic acid sequence;
wherein the DNA nanostructure is a DNA tetrahedron comprising five double-stranded edges and one single-stranded edge; and
wherein the target viral nucleic acid sequence is a sequence from a virus selected from dengue virus, Ebola virus, human immunodeficiency virus (HIV), hepatitis B, hepatitis C, influenza, measles, Zika, yellow fever, West Nile fever, smallpox, Marburg viruses, human papillomavirus, Kaposi's sarcoma-associated herpesvirus, and human T-lymphotropic virus.
|